Necrobiosis lipoidica with bone involvement successfully treated with infliximab

Rheumatology (Oxford). 2019 Sep 1;58(9):1702-1703. doi: 10.1093/rheumatology/kez055.

Authors

Laura Fertitta¹, Marie-Dominique Vignon-Pennamen², Aline Frazier³, Fabien Guibal¹, Eric Caumes⁴, Martine Bagot¹, Jean-David Bouaziz¹, Laure Frumholtz¹

Affiliations

¹ Department of Dermatology.
² Department of Pathology, Hôpital Saint Louis, AP-HP.
³ Department of Rheumatology, Hôpital Lariboisière, AP-HP.
⁴ Department of Infectious Diseases, Hôpital Pitié - Salpétrière AP-HP, Paris, France.

PMID: 30877774
DOI: 10.1093/rheumatology/kez055

No abstract available

Publication types

Case Reports

MeSH terms

Antirheumatic Agents / therapeutic use*
Bone Diseases / drug therapy*
Bone Diseases / etiology
Elbow Joint
Humans
Infliximab / therapeutic use*
Male
Middle Aged
Necrobiosis Lipoidica / complications
Necrobiosis Lipoidica / drug therapy*

Substances

Antirheumatic Agents
Infliximab